Oncogenicity of the transcription factor SOX8 in hepatocellular carcinoma

Medical Oncology

Volumn 31, Issue 4, 2014, Pages

  Zhang, Siquan ^a,b   Zhu, Cong ^a,c   Zhu, Limin ^a   Liu, Huafeng ^b   Liu, Shourong ^b   Zhao, Nianbo ^b   Wu, Jing ^b   Huang, Xiaoxiao ^b   Zhang, Yujuan ^b   Jin, Jie ^b   Ji, Ting ^a   Ding, Xianfeng ^a  

^a ZHEJIANG SCI TECH UNIVERSITY   (China)

^b Hangzhou Xixi Hospital   (China)

^c Zhejiang Institute of Microbiology   (China)

Author keywords

HCC; Oncogene; SOX8; Catenin

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR SOX8; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; SOX10 PROTEIN, HUMAN; SOX8 PROTEIN, HUMAN; SOX9 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX; TRANSCRIPTION FACTOR SOX9;

ARTICLE; CANCER CELL; CANCER TISSUE; CARCINOGENICITY; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; UPREGULATION; CELL PROLIFERATION; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; LIVER TUMOR; METABOLISM; SIGNAL TRANSDUCTION; TIME;

BETA CATENIN; CARCINOMA, HEPATOCELLULAR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; SIGNAL TRANSDUCTION; SOX9 TRANSCRIPTION FACTOR; SOXE TRANSCRIPTION FACTORS; TIME FACTORS;

EID: 84898833856     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-014-0918-3     Document Type: Article

References (28)

1. Tanaka S, Arii S. Molecular targeted therapies in hepatocellular carcinoma. Semin Oncol. 2012;39(4):486-92.
2. Vinas A, et al. Mapping of DNA sex-specific markers and genes related to sex differentiation in turbot (Scophthalmus maximus). Mar Biotechnol (NY). 2012;14(5):655-63.
3. Ng CK, et al. Deciphering the Sox-Oct partner code by quantitative cooperativity measurements. Nucleic Acids Res. 2012;40(11):4933-41.
4. Coco C, et al. Increased expression of CD133 and reduced dystroglycan expression are strong predictors of poor outcome in colon cancer patients. J Exp Clin Cancer Res. 2012;31:71.
5. Zhang W, et al. Epigenetic inactivation of the canonical Wnt antagonist SRY-box containing gene 17 in colorectal cancer. Cancer Res. 2008;68(8):2764-72.
6. Scott EL, Brann DW. Estrogen regulation of Dkk1 and Wnt/beta-catenin signaling in neurodegenerative disease. Brain Res. 2013;1514:63-74.
7. Laudet V, Stehelin D, Clevers H. Ancestry and diversity of the HMG box superfamily. Nucleic Acids Res. 1993;21(10):2493-501.
8. Cao JM, et al. High mobility group B proteins regulate mesoderm formation and dorsoventral patterning during zebrafish and Xenopus early development. Mech Dev. 2012;129(9-12):263-74.
9. Marchetti B, et al. Uncovering novel actors in astrocyte-neuron crosstalk in Parkinson's disease: the Wnt/beta-catenin signaling cascade as the common final pathway for neuroprotection and self-repair. Eur J Neurosci. 2013;37(10):1550-63.
10. Hu S, et al. Sox31 is involved in central nervous system anteroposterior regionalization through regulating the organizer activity in zebrafish. Acta Biochim Biophys Sin (Shanghai). 2011;43(5):387-99.
11. Aksoy I, et al. Sox transcription factors require selective interactions with Oct4 and specific transactivation functions to mediate reprogramming. Stem Cells. 2013;31(12):2632-46.
12. Jiang T, et al. The SOX gene family: function and regulation in testis determination and male fertility maintenance. Mol Biol Rep. 2013;40(3):2187-94.
13. Goding CR. Melanocyte development and malignant melanoma. Forum (Genova). 2000;10(3):176-87.
14. Soullier S, et al. Diversification pattern of the HMG and SOX family members during evolution. J Mol Evol. 1999;48(5):517-27.
15. Argenton F, et al. Ectopic expression and knockdown of a zebrafish sox21 reveal its role as a transcriptional repressor in early development. Mech Dev. 2004;121(2):131-42.
16. Juarez M, et al. Characterization of the trunk neural crest in the bamboo shark, Chiloscyllium punctatum. J Comp Neurol. 2013;521(14):3303-20.
17. Lakiza O, et al. SoxE gene duplication and development of the lamprey branchial skeleton: insights into development and evolution of the neural crest. Dev Biol. 2011;359(1):149-61.
18. Lavery R, et al. Testicular differentiation occurs in absence of R-spondin1 and Sox9 in mouse sex reversals. PLoS Genet. 2012;8(12):e1003170.
19. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 2008;8(5):387-98.
20. Liu Q, et al. Homologues of sox8 and sox10 in the orange-spotted grouper Epinephelus coioides: sequences, expression patterns, and their effects on cyp19a1a promoter activities in vitro. Comp Biochem Physiol B: Biochem Mol Biol. 2012;163(1):86-95.
21. Baarsma HA, et al. Activation of WNT/beta-catenin signaling in pulmonary fibroblasts by TGF-beta(1) is increased in chronic obstructive pulmonary disease. PLoS ONE. 2011;6(9):e25450.
22. Vijayakumar S, et al. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/beta-catenin target gene, CDC25A. Cancer Cell. 2011;19(5):601-12.
23. Kormish JD, Sinner D, Zorn AM. Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn. 2010;239(1):56-68.
24. Korbut E, Ptak-Belowska A, Brzozowski T. Mechanisms promoting physiological cells progression into tumorigenesis. J Physiol Pharmacol. 2012;63(6):565-70.
25. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer. 2006;6(2):107-16.
26. L'Episcopo F, et al. Reactive astrocytes and Wnt/beta-catenin signaling link nigrostriatal injury to repair in 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine model of Parkinson's disease. Neurobiol Dis. 2011;41(2):508-27.
27. Bafico A, et al. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004;6(5):497-506.
28. Liu F, Millar SE. Wnt/beta-catenin signaling in oral tissue development and disease. J Dent Res. 2010;89(4):318-30.